OBJECTIVE: To compare the therapeutic effects of vitamin D3 plus fluoxetine and fluoxetine alone in patients with major depressive disorder. METHODS: In the present double-blind, randomized, placebo-controlled trial, 42 patients with a diagnosis of major depressive disorder based on DSM-IV criteria were randomly assigned into two groups to receive daily either 1500 IU vitamin D3 plus 20 mg fluoxetine or fluoxetine alone for 8 weeks. Depression severity was assessed at 2-week intervals using the 24-item Hamilton Depression Rating Scale (HDRS) as a primary outcome measure and the 21-item Beck Depression Inventory (BDI) as a secondary outcome measure. Serum 25(OH) vitamin D was measured at baseline and after intervention. RESULTS:Forty patients completed the trial. A two-way repeated-measures analysis of variance showed that depression severity based on HDRS and BDI decreased significantly after intervention, with a significant difference between the two groups. The vitamin D + fluoxetine combination was significantly better than fluoxetine alone from the fourth week of treatment. CONCLUSIONS: In the present 8-week trial, the vitamin D + fluoxetine combination was superior to fluoxetine alone in controlling depressive symptoms.
RCT Entities:
OBJECTIVE: To compare the therapeutic effects of vitamin D3 plus fluoxetine and fluoxetine alone in patients with major depressive disorder. METHODS: In the present double-blind, randomized, placebo-controlled trial, 42 patients with a diagnosis of major depressive disorder based on DSM-IV criteria were randomly assigned into two groups to receive daily either 1500 IU vitamin D3 plus 20 mg fluoxetine or fluoxetine alone for 8 weeks. Depression severity was assessed at 2-week intervals using the 24-item Hamilton Depression Rating Scale (HDRS) as a primary outcome measure and the 21-item Beck Depression Inventory (BDI) as a secondary outcome measure. Serum 25(OH) vitamin D was measured at baseline and after intervention. RESULTS: Forty patients completed the trial. A two-way repeated-measures analysis of variance showed that depression severity based on HDRS and BDI decreased significantly after intervention, with a significant difference between the two groups. The vitamin D + fluoxetine combination was significantly better than fluoxetine alone from the fourth week of treatment. CONCLUSIONS: In the present 8-week trial, the vitamin D + fluoxetine combination was superior to fluoxetine alone in controlling depressive symptoms.
Authors: Jonathan A Shaffer; Donald Edmondson; Lauren Taggart Wasson; Louise Falzon; Kirsten Homma; Nchedcochukwu Ezeokoli; Peter Li; Karina W Davidson Journal: Psychosom Med Date: 2014-04 Impact factor: 4.312
Authors: David C R Kerr; David T Zava; Walter T Piper; Sarina R Saturn; Balz Frei; Adrian F Gombart Journal: Psychiatry Res Date: 2015-03-05 Impact factor: 3.222
Authors: Elif M Sikoglu; Ana A Liso Navarro; Debra Starr; Yael Dvir; Benjamin Udoka Nwosu; Suzanne M Czerniak; Ryan C Rogan; Martha C Castro; Richard A E Edden; Jean A Frazier; Constance M Moore Journal: J Child Adolesc Psychopharmacol Date: 2015-06 Impact factor: 2.576
Authors: G Michael Allan; Lynda Cranston; Adrienne Lindblad; James McCormack; Michael R Kolber; Scott Garrison; Christina Korownyk Journal: J Gen Intern Med Date: 2016-03-07 Impact factor: 5.128
Authors: Gleicilaine A S Casseb; Gabriela Ambrósio; Ana Lúcia S Rodrigues; Manuella P Kaster Journal: Metab Brain Dis Date: 2019-01-02 Impact factor: 3.584